Biofrontera INC Schedule 13G passive stakes

Rosalind Advisors, Inc. and affiliated entities have filed a Schedule 13G, reporting a beneficial ownership of 9.9% in Biofrontera Inc., with significant details on potential share issuances.

Rosalind Advisors and affiliated entities report a 9.9% passive beneficial ownership in Biofrontera Inc., primarily through common stock, preferred shares, and convertible debt, subject to a 9.99% ownership blocker.

AIGH Capital Management LLC and Orin Hirschman report a 7.9% beneficial ownership stake in Biofrontera Inc. as of December 31, 2025.

Rosalind Advisors, Steven Salamon, Gilad Aharon, and Rosalind Master Fund L.P. jointly report a 9.9% beneficial ownership in Biofrontera Inc. common shares.

Rosalind Advisors and related entities report a 9.9% beneficial ownership in Biofrontera Inc., constrained by a 9.99% blocker provision on convertible securities.

Laurence W. Lytton has filed an amended Schedule 13G, reporting beneficial ownership of 3.5% of Biofrontera Inc.'s common stock as of March 31, 2025.

Rosalind Advisors, Inc. and affiliated entities have filed an amended Schedule 13G, reporting a 9.9% beneficial ownership stake in Biofrontera Inc.'s common shares, primarily through preferred shares and convertible debt, subject to a 9.99% blocker provision.

Rosalind Advisors, Inc. and its affiliates, including Rosalind Master Fund L.P., reported a continued beneficial ownership of 9.9% of Biofrontera Inc.'s common stock as of December 31, 2024, primarily through common shares, preferred shares, and convertible debt, subject to a 9.99% blocker provision.

AIGH Capital Management LLC and Orin Hirschman have filed an amended Schedule 13G, reporting a passive beneficial ownership of 9.9% of Biofrontera Inc.'s common stock as of December 31, 2024.